Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49927,6407,0.78 [0.73-0.84],2.345029453664743e-13
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45578,2207,0.73 [0.65-0.81],1.9951839820196777e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36001,3969,0.76 [0.70-0.83],2.1570052003882158e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49954,5804,0.69 [0.64-0.74],1.9103605881353823e-27
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50570,3038,0.62 [0.57-0.68],2.7287555567272277e-25
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50568,3036,0.62 [0.57-0.68],2.8111452586957075e-25
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50881,2390,0.51 [0.47-0.57],4.739066966665205e-42
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39842,633,0.56 [0.46-0.69],2.3661550606939843e-08
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46285,7076,0.80 [0.75-0.85],7.028767553409191e-12
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39592,383,0.47 [0.37-0.60],2.484498007700722e-09
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39803,594,0.43 [0.35-0.52],1.6802447160568013e-18
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40473,1264,0.63 [0.54-0.73],3.3793135575135956e-10
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40411,1202,0.49 [0.43-0.57],5.128143535985492e-23
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49183,9974,0.82 [0.78-0.87],7.73756932285576e-13
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42371,3162,0.61 [0.55-0.67],1.1947665393578923e-26
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51508,453,0.36 [0.30-0.43],1.7921389958045122e-27
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46880,309,0.39 [0.33-0.47],1.2372884802161632e-24
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4525,508,0.45 [0.37-0.54],4.6822382006596425e-17
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50252,3681,0.51 [0.47-0.55],6.737468464865923e-64
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40750,1541,0.65 [0.57-0.74],1.6693863541978536e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Angina pectoris,47054,2383,0.74 [0.66-0.82],2.9026917902085072e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31967,3818,0.60 [0.55-0.65],3.7412179122238206e-32
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,AV-block,43401,858,0.62 [0.52-0.74],8.947867126257664e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Conduction disorders,44640,2097,0.70 [0.62-0.78],6.643866635147801e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44977,15111,0.80 [0.76-0.83],1.1840508087018644e-23
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51122,2202,0.71 [0.64-0.80],1.215810472094741e-09
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertension,46810,12982,0.70 [0.67-0.73],5.246133226847909e-52
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46846,13018,0.70 [0.66-0.73],1.128140732178935e-52
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34095,267,0.39 [0.32-0.49],5.966682753512213e-17
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypotension,51247,2358,0.72 [0.65-0.80],1.946220384612624e-09
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50571,1678,1.48 [1.29-1.69],1.2529659815560104e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46085,1414,1.52 [1.31-1.77],3.8098312257027014e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51344,307,3.09 [2.22-4.29],1.6860334112202587e-11
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44613,2070,0.71 [0.63-0.80],4.875666424650664e-09
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50034,1077,0.61 [0.52-0.71],2.2641461401005638e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28828,679,0.49 [0.41-0.60],4.864779738637328e-13
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49699,804,0.56 [0.47-0.67],1.2465679841182558e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50348,5157,0.80 [0.75-0.87],7.425360561777279e-09
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51187,468,0.32 [0.28-0.36],2.540510709740318e-69
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4195,121,0.35 [0.24-0.51],5.042899495555922e-08
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51103,2066,0.57 [0.51-0.63],4.855647268864634e-24
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50382,3247,0.77 [0.70-0.84],1.923885943799732e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47610,475,0.53 [0.42-0.66],2.529890373463513e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40604,4967,0.81 [0.75-0.87],2.2026153681609283e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47474,3096,0.77 [0.70-0.84],2.7553515709224856e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49443,3158,0.68 [0.62-0.75],3.6077538666768243e-16
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49341,3056,0.60 [0.55-0.65],1.6944641635356386e-28
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43001,10718,0.82 [0.78-0.87],1.0649781571397537e-13
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51109,167,0.33 [0.25-0.43],2.6084785952616943e-15
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51035,5347,0.71 [0.66-0.76],3.24199700602818e-21
